Envoy Medical (COCH) Long-Term Deferred Tax (2021 - 2023)

Envoy Medical has disclosed Long-Term Deferred Tax across 3 years of filings, most recently posting $50.2 million for Q4 2023.

• In Q4 2023, Long-Term Deferred Tax rose 13.08% year-over-year to $50.2 million; the TTM figure through Dec 2023 stood at $50.2 million (up 13.08% YoY), while the FY2023 annual figure was $50.2 million, up 13.08% from the prior year.
• Long-Term Deferred Tax came in at $50.2 million for Q4 2023 at Envoy Medical, up from $44.4 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $50.2 million in Q4 2023 to a low of $7910.0 in Q4 2021.
• Average Long-Term Deferred Tax over 3 years is $31.6 million, with a median of $44.4 million recorded in 2022.
• Year-over-year, Long-Term Deferred Tax jumped 561442.35% in 2022 and gained 13.08% in 2023.
• Over 3 years, Long-Term Deferred Tax stood at $7910.0 in 2021, then jumped by 561442.35% to $44.4 million in 2022, then grew by 13.08% to $50.2 million in 2023.
• Per Business Quant data, the three most recent Long-Term Deferred Tax figures were $50.2 million in Q4 2023, $44.4 million in Q4 2022, and $7910.0 in Q4 2021.